American Association for Cancer Research
Browse
00085472can133132-sup-122019_1_supp_2493943_n6pwvf.png (828.91 kB)

Supplemental Figure S3 from Cytokine-like Molecule CCDC134 Contributes to CD8+ T-cell Effector Functions in Cancer Immunotherapy

Download (828.91 kB)
figure
posted on 2023-03-30, 22:31 authored by Jing Huang, Lin Xiao, Xiaoting Gong, Wenwei Shao, Yanhui Yin, Qinyuan Liao, Yang Meng, Yingmei Zhang, Dalong Ma, Xiaoyan Qiu

Identification of established CCDC134 transgenic mice.

History

ARTICLE ABSTRACT

CCDC134 is a poorly characterized secreted protein that may act as an immune cytokine. Here, we show that CCDC134 is differentially expressed on resting and activated immune cells and that it promotes CD8+ T-cell activation, proliferation, and cytotoxicity by augmenting expression of the T-cell effector molecules IFNγ, TNFα, granzyme B, and perforin. CCDC134 facilitated infiltration of CD8+ T cells with enhanced cytolytic activity into tumors, demonstrating strong antitumor effects in a CD8+ T-cell–dependent manner. Mechanistically, in CD8+ T cells, exposure to CCDC134 promoted cell proliferation through the JAK3–STAT5 pathway, a classic feature of many cytokines of the common γ-chain (γc) cytokine receptor family. Overall, our results provide evidence that CCDC134 may serve as a member of the γc cytokine family and illustrate its potent antitumor effects by augmenting CD8+ T-cell–mediated immunity. Cancer Res; 74(20); 5734–45. ©2014 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC